Beverly D. Smolich

SU11248 is a novel FLT3 tyrosine kinase inhibitor with potent activity in vitro and in vivo

Anne-Marie O'Farrell, Tinya J. Abrams, Helene A. Yuen et al. · Blood · 2003 · 856 citations · Full text

Development of SU5416, a selective small molecule inhibitor of VEGF receptor tyrosine kinase activity, as an anti-angiogenesis agent.

Dirk B. Mendel, Alexander Laird, Beverly D. Smolich et al. · PubMed · 2000 · 234 citations

Anti-angiogenesis Agent, Receptor Tyrosine, Angiogenesis +14

The antiangiogenic protein kinase inhibitors SU5416 and SU6668 inhibit the SCF receptor (c-kit) in a human myeloid leukemia cell line and in acute myeloid leukemia blasts

Beverly D. Smolich, Helene A. Yuen, Kristina West et al. · Blood · 2001 · 180 citations

Wnt family proteins are secreted and associated with the cell surface.

Beverly D. Smolich, Jill A. McMahon, Andrew P. McMahon et al. · Molecular Biology of the Cell · 1993 · 173 citations · Full text

Protein Secretion, Wnt Gene Family, Cellular Physiology +18

SU5416 and SU5614 inhibit kinase activity of wild-type and mutant FLT3 receptor tyrosine kinase

Kevin Yee, A O’Farrell, Beverly D. Smolich et al. · Blood · 2002 · 164 citations